Literature DB >> 5664330

Absorption, excretion and half-life of clinimycin in normal adult males.

J G Wagner, E Novak, N C Patel, C G Chidester, W L Lummis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5664330     DOI： 10.1097/00000441-196807000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  21 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

3.  The effect of cirrhosis on the disposition and elimination of clindamycin.

Authors:  G R Avant; S Schenker; R H Alford
Journal:  Am J Dig Dis       Date:  1975-03

Review 4.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

6.  [Interactions between nutrition and drugs].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1976-06

7.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

8.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

9.  Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS.

Authors:  G Gatti; M Malena; R Casazza; M Borin; M Bassetti; M Cruciani
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.

Authors:  J F Flaherty; L C Rodondi; B J Guglielmo; J C Fleishaker; R J Townsend; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.